Stage III Non-Small Cell Lung Cancer AJCC v7 Terminated Phase 2 Trials for Durvalumab (DB11714)

Also known as: Stage III Lung Non-Small Cell Cancer AJCC v7

IndicationStatusPhase
DBCOND0090379 (Stage III Non-Small Cell Lung Cancer AJCC v7)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02452463Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation TherapySupportive Care